newsfilter
← Latest News
GlobeNewswire·

NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress

NAARDEN, the Netherlands and MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients